Skip to main content
. 2009 Jul 20;4(7):e6312. doi: 10.1371/journal.pone.0006312

Figure 2. Effects of thalidomide treatment on MPO activity, TNF-α and VEGF content within the grafted kidneys.

Figure 2

The retrieved grafted kidneys from C57Bl/6 recipients were subjected to Myeloperoxidase (MPO) assay (A) or specific mouse immunoassay for TNF-α (B) or VEGF (C). N = 6 in each assay. **p<0.01 vs vehicle control mouse kidneys.